FLUORINOV PHARMA

fluorinov-pharma-logo

Fluorinov Pharma Inc., a privately-held oncology company.

#Website #More

FLUORINOV PHARMA

Industry:
Biotechnology

Founded:
2008-01-01

Website Url:
http://www.fluorinovpharma.com

Total Employee:
11+

Status:
Closed

Technology used in webpage:
Domain Not Resolving


Official Site Inspections

http://www.fluorinovpharma.com

Unable to get host informations!!!

Loading ...

More informations about "Fluorinov Pharma"

Fluorinov Pharma - Crunchbase Company Profile & Funding

Organization. Fluorinov Pharma . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. Fluorinov Pharma Inc., a privately-held oncology company. ...See details»

Fluorinov Pharma Company Profile 2024: Valuation, Investors ...

Fluorinov Pharma General Information Description. Operator of a pharmaceutical company intended to develop fluorine-based novel, safer and more effective medicine. The company's โ€ฆSee details»

Fluorinov Pharma, Inc. - Drug pipelines, Patents, Clinical trials

Explore Fluorinov Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 9 literature, Drug:FV-009.See details»

Fluorinov Pharma Inc - Company Profile and News

Fluorinov Pharma Inc., is a pharmaceutical company. The Company researches and develops novel drugs for the treatment of cancers and central nervous system disorders. ...See details»

Fluorinov Pharma Inc. develops drug for the treatment of blood

Fluorinov Pharma Inc. Fluorinov Pharma is a privately owned biopharmaceutical company that initiated discovery operations in Toronto, Canada in 2008. Fluorinov rapidly discovers and โ€ฆSee details»

Fluorinov Pharma Inc Company Profile | Toronto, ON, Canada ...

Find company research, competitor information, contact details & financial data for Fluorinov Pharma Inc of Toronto, ON. Get the latest business insights from Dun & Bradstreet. D&B โ€ฆSee details»

Fluorinov, FACIT and OICR announce novel candidate drugs

TORONTO, ON (April 24, 2014) โ€“ Fluorinov Pharma, an emerging Ontario-based drug development company, has developed three structurally distinct candidate drugs that โ€ฆSee details»

Trillium Therapeutics Acquires Fluorinov Pharma - Ontario โ€ฆ

Jan 28, 2016 Combined entity creates strong foundation for leading Canadian immuno-oncology company TORONTO, ON (January 28, 2016) โ€“ FACIT has announced that Trillium โ€ฆSee details»

Trillium Therapeutics Acquires Fluorinov Pharma - FACIT

Trillium Therapeutics Acquires Fluorinov Pharma Combined entity creates strong foundation for leading Canadian immuno-oncology company. TORONTO, ON (January 28, 2016) โ€“ FACIT has announced that Trillium Therapeutics Inc. โ€ฆSee details»

Trillium Therapeutics Acquires Fluorinov Pharma - Newswire

Jan 28, 2016 /CNW/ - FACIT has announced that Trillium Therapeutics Inc. (NASDAQ:TRIL, TSX:TR; "Trillium") has acquired all of the outstanding shares of privately-held...See details»

Trillium Acquires Privately-Held Fluorinov Pharma Inc.

Jan 27, 2016 Trillium Acquires Privately-Held Fluorinov Pharma Inc. - Proprietary industry-leading fluorine-based medicinal chemistry platform providing an internal engine to generate โ€ฆSee details»

Trillium Acquires Fluorinov - Technology Networks

Jan 28, 2016 Trillium Therapeutics Inc. a clinical immuno-oncology company developing innovative therapies for the treatment of cancer, has announced that it has acquired all of the โ€ฆSee details»

OICR Funds Fluorinov Pharma Inc To Further Develop Its Novel โ€ฆ

The Ontario Institute for Cancer Research (OICR) today announced $1.5 million in funding over three years for the development of a new drug by Toronto-based Fluorinov Pharma, Inc. The โ€ฆSee details»

OICR funds Fluorinov Pharma Inc. to further develop its

Jun 7, 2012 /CNW/ - The Ontario Institute for Cancer Research (OICR) today announced $1.5 million in funding over three years for the development of a new drug by...See details»

Fluorinov Pharma, FACIT and OICR announce novel candidate

Apr 24, 2014 /CNW/ - Fluorinov Pharma, an emerging Ontario-based drug development company, has developed three structurally distinct candidate drugs that selectively target...See details»

Fluorinov Pharma and FACIT Announce Investment in โ€ฆ

Jan 7, 2015 About Fluorinov Pharma The incorporation of fluorine into drug structures can improve potency, stability and safety, and other critical drug attributes. Innovative โ€ฆSee details»

Fluorinov Pharma and FACIT Announce Investment in โ€ฆ

TORONTO, ON (January 07, 2015) โ€“ FACIT and Fluorinov Pharma announced today an investment in the development of highly potent inhibitors of key bromodomain targets. โ€ฆSee details»

Research programme: fluorinated CNS and cancer therapeutics

Originator Fluorinov Pharma Developer Trillium Therapeutics Inc Class ... Contacting your organizationโ€™s admin about adding this content to your AdisInsight subscription Buying a PDF โ€ฆSee details»

Trillium Therapeutics Acquires Fluorinov Pharma - PR Newswire

Jan 28, 2016 Combined entity creates strong foundation for leading Canadian immuno-oncology company . TORONTO, Jan. 28, 2016 /PRNewswire/ - FACIT has announced that Trillium โ€ฆSee details»

Fluorinov Pharma and FACIT Announce Investment in โ€ฆ

Jan 7, 2015 /CNW/ - FACIT and Fluorinov Pharma announced today an investment in the development of highly potent inhibitors of key bromodomain targets. Targeting drugs to...See details»